We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13B
AUM Growth
+$984M
Cap. Flow
+$180M
Cap. Flow %
1.38%
Top 10 Hldgs %
38.14%
Holding
1,449
New
52
Increased
710
Reduced
341
Closed
132

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$287M
2
DLR icon
Digital Realty Trust
DLR
+$150M
3
HR icon
Healthcare Realty
HR
+$110M
4
WELL icon
Welltower
WELL
+$106M
5
O icon
Realty Income
O
+$88.1M

Top Sells

Rank Stock Value
1
DRE
Duke Realty Corp.
DRE
+$310M
2
SPG icon
Simon Property Group
SPG
+$93.4M
3
FR icon
First Industrial Realty Trust
FR
+$90.7M
4
PSA icon
Public Storage
PSA
+$88.6M
5
DOC icon
Healthpeak Properties
DOC
+$58M

Sector Composition

Rank Sector Weight
1 Real Estate 57.53%
2 Technology 9.67%
3 Healthcare 4.73%
4 Financials 4.38%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDNY
1126
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$6K ﹤0.01%
230
– –
DICE
1127
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$6K ﹤0.01%
+192
New +$6.26K
ACLX
1128
DELISTED
Arcellx
ACLX
$5K ﹤0.01%
+176
New +$4.04K
AMPH icon
1129
Amphastar Pharmaceuticals
AMPH
$911M
$5K ﹤0.01%
194
+29
+18% +$842
DBC icon
1130
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$5K ﹤0.01%
200
+100
+100% +$2.51K
KROS icon
1131
Keros Therapeutics
KROS
$199M
$5K ﹤0.01%
111
+31
+39% +$1.45K
MYGN icon
1132
Myriad Genetics
MYGN
$488M
$5K ﹤0.01%
326
+59
+22% +$1.1K
REPL icon
1133
Replimune Group
REPL
$455M
$5K ﹤0.01%
200
+40
+25% +$831
TVTX icon
1134
Travere Therapeutics
TVTX
$5.28B
$5K ﹤0.01%
258
+50
+24% +$1.06K
TWST icon
1135
Twist Bioscience
TWST
$5.45B
$5K ﹤0.01%
210
– –
EQRX
1136
DELISTED
EQRx, Inc. Common Stock
EQRX
$5K ﹤0.01%
+1,964
New +$7.74K
ACRS icon
1137
Aclaris Therapeutics
ACRS
$722M
$4K ﹤0.01%
248
– –
ADPT icon
1138
Adaptive Biotechnologies
ADPT
$3.6B
$4K ﹤0.01%
530
– –
ARQT icon
1139
Arcutis Biotherapeutics
ARQT
$3.52B
$4K ﹤0.01%
245
+73
+42% +$1.27K
CRNX icon
1140
Crinetics Pharmaceuticals
CRNX
$8.88B
$4K ﹤0.01%
199
– –
FATE icon
1141
Fate Therapeutics
FATE
$280M
$4K ﹤0.01%
360
– –
IDYA icon
1142
IDEAYA Biosciences
IDYA
$3.49B
$4K ﹤0.01%
193
+61
+46% +$1.03K
IOVA icon
1143
Iovance Biotherapeutics
IOVA
$2.09B
$4K ﹤0.01%
586
– –
LGND icon
1144
Ligand Pharmaceuticals
LGND
$5.83B
$4K ﹤0.01%
63
-38
-38% -$2.47K
PLRX icon
1145
Pliant Therapeutics
PLRX
$66.9M
$4K ﹤0.01%
196
+73
+59% +$1.53K
QURE icon
1146
uniQure
QURE
$2.77B
$4K ﹤0.01%
158
– –
VERV
1147
DELISTED
Verve Therapeutics
VERV
$4K ﹤0.01%
221
– –
ZNTL icon
1148
Zentalis Pharmaceuticals
ZNTL
$335M
$4K ﹤0.01%
212
– –
MORF
1149
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$4K ﹤0.01%
155
+47
+44% +$1.28K
DCPH
1150
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4K ﹤0.01%
272
+73
+37% +$1.19K
44 45
46
47 48

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q4 2022 Portfolio in Review

As of Q4 2022, Daiwa Securities Group held 1,449 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q4 2022 filing shows 52 new, 710 increased, 341 reduced and 132 closed positions. Its largest new stake was Atlassian: 9,371 shares worth $1.21M. The largest sale was Duke Realty Corp., an estimated $310M.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q4 2022 buy was Atlassian: 9,371 shares worth $1.21M.
  • Daiwa Securities Group added most to Prologis in Q4 2022, an estimated $287M increase.
  • Daiwa Securities Group's biggest Q4 2022 reduction was Simon Property Group, cutting an estimated $93.4M.
  • Daiwa Securities Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $310M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13B portfolio in Q4 2022.
  • Daiwa Securities Group opened 52 new positions and closed 132 in Q4 2022.
  • Daiwa Securities Group's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.